The Gary Null Show - 01.29.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

Meta-analysis finds dietary supplements improve sleep quality

Hong Kong Polytechnic University, January 27 2021. 

A systematic review and meta-analysis published on January 13, 2021 in Postgraduate Medical Journal found benefits for supplemental vitamin D, melatonin and amino acids in improving the quality of sleep among men and women. 

The meta-analysis included 15 randomized, controlled trials that examined the association between subjective sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) and supplementation with amino acids, the hormone melatonin, omega 3 fatty acids and vitamin D. Pooled data for the two studies involving amino acid supplements, seven studies involving melatonin, and four studies involving vitamin D each showed significant differences between supplemented and control groups, with more favorable PSQI scores occurring among those who received the supplements. The two studies that evaluated omega 3 did not reveal significant differences between the treatment and control groups.

Two reviewed trials that were not eligible for inclusion in the meta-analysis added evidence to the benefit of melatonin in sleep quality. Other non-included trials found a benefit for nitrate-containing beetroot juice, resveratrol and zinc supplements. Co-supplementation with melatonin, magnesium and zinc was also associated with a significant benefit in comparison with a placebo. 

“Although we found a significant improvement in sleep quality by dietary supplementation, randomized, controlled trials with longer duration and larger sample size should be conducted to verify our findings,” noted authors Vicky Chan and Kenneth Lo of The Hong Kong Polytechnic University. “Furthermore, dose–response effect of different supplements on sleep quality has not yet been evaluated.”

“Amino acids, vitamin D and melatonin supplements were significantly beneficial to improve sleep quality,” they concluded. “Further research on the effect of magnesium, zinc, resveratrol and nitrate supplementation on improving sleep quality is required.”

The study plans to conduct further analysis on groups at particularly high risk, such as people with cognitive impairment and those with caring rolesG

The Gary Null Show - 01.28.21

Statement of Harvey A. Risch, MD, PhD
Professor of Epidemiology, Yale School of Public Health
Senators and colleagues: thank you for convening this hearing. We all understand the endemic
disease that we are facing, that we have to face it head-on and not hide from it hoping that it
will go away. I want to give you my perspective.
In May of this year I observed that results of studies of a drug suggested to treat Covid,
hydroxychloroquine, were being misrepresented by what I thought at the time was sloppy
reporting. We have heard from Dr. McCullough how Covid disease progresses in phases, from
viral replication, to florid pneumonia to multi-organ attack. Viral replication is an outpatient
condition, but the pneumonia that fills the lungs with immune-system debris is hospitalizable
and potentially life-threatening. We have also heard how each phase, each pathologic aspect
of the disease, has to have its own specific treatments that apply to its own biologic
mechanisms. Thus, I was frankly astounded that studies of hospital treatments were being
represented as applying to outpatients, in violation of what I learned in medical school about
how to treat patients.
We are now finally coming to address why over the last six months, our government research
institutions have invested billions of dollars in expensive patent medication and vaccine
development but almost nothing in early outpatient treatment, the first line of response to
managing the pandemic. It is not that we lacked candidate medications to study, we have had
a number of promising agents. But I believe that the early-on conflation of hospital with
outpatient disease served to imply that treatment of outpatient disease had been studied and
found ineffective. This illogical premise motivated me to look at the evidence for outpatient
treatment.
I reiterate: we are considering the evidence for early treatment of high-risk outpatients to
prevent hospitalization and mortality. That is it. Treatment starting in the first five days or so
after the onset of symptoms. Treatment of older patients or patients with chronic conditions
such as diabetes, obesity, heart diseases, lung diseases, kidney diseases, immune-system
diseases, survivors of cancer etc. These are the people most likely to die from Covid, and they
are the people most needing protection. I have sought to obtain reports of every study of
every medication pertaining to early treatment of high-risk outpatients. I monitor the literature
daily. And what I have found is actually quite remarkable. What I have observed is that while
there have been positive reports about a number of drugs, every study of outpatient use of one
drug, hydroxychloroquine, with or without accompanying agents, has shown substantial benefit
in reducing risks of hospitalization and mortality.
These studies break down into two major types. The first is double-blinded, randomized
controlled trials, and the second is non-randomized but still controlled trials. You have heard
from various government and scientific personalities that randomized controlled trials provide
the strongest form of evidence. Many of these people have also claimed that randomized trials 
provide the only trustworthy form of evidence. There is some truth in these assertions, but
there is also lots of falsehood. We know for example that the great majority of drugs used to
treat heart diseases were established with non-randomized trials. Cholesterol-lowering drugs
were in widespread use before randomized trials were ever done. Azithromycin, the most
commonly used antibiotic in children, was not established by randomized trials. The idea that
only randomized trials provide trustworthy evidence is a simplistic notion that may sound good
in theory, but the comparison between randomized and non-randomized trials is something
that has actually been extensively studied in the medical literature. I am an epidemiologist
because even though I love biological theories, I develop them all the time to study how nature
works, but it is from the human empirical data that we learn how indeed nature works.
And we have huge amounts of empirical data to show that randomized trials and their
corresponding non-randomized trials give the same answers. Dr. Tom Frieden, previously
Director of the CDC, in 2017 wrote an extensive essay in the New England Journal of Medicine
showing that non-randomized trials can provide fully compelling evidence, especially when they
are done carefully to account for reasons why patients received the drugs, and importantly,
when circumstances are such that the cost of waiting for randomized trials involves major
sickness and mortality as we have been experiencing this year. But Dr. Frieden’s essay, as
authoritative as it is, provides only snapshots of the empirical evidence for his observations.
The real evidence comes from a meta-analysis of meta-analyses done by the Cochrane Library
Consortium, a British international organization formed to organize medical research findings to
facilitate evidence-based choices about health interventions. The Cochrane investigators
examined what involve tens of thousands of comparisons between randomized trials and their
non-randomized counterparts and found that the two types of studies arrived at virtually
identical conclusions. This is the real evidence about why good non-randomized trials comprise
evidence every bit as important as randomized trials. Large amounts of consistent empirical
data are the evidence, not plausible but simplistic assumptions, no matter who says them.
So what did I find about hydroxychloroquine in early use among high-risk outpatients? The first
thing is that hydroxychloroquine is exceedingly safe. Common sense tells us this, that a
medication safely used for 65 years by hundreds of millions of people in tens of billions of doses
worldwide, prescribed without routine screening EKGs, given to adults, children, pregnant
women and nursing mothers, must be safe when used in the initial viral-replication phase of an
illness that is similar at that point to colds or flu. In fact, a study by researchers at the
University of Oxford showed that in 14 large international medical-records databases of older
rheumatoid arthritis patients, no significant differences were seen in all-cause mortality for
patients who did or did not use hydroxychloroquine. The Oxford investigators also looked at
cardiac arrhythmias and found no increase for hydroxychloroquine users. This was in more
than 900,000 hydroxychloroquine users. This is examined at length in my paper in the
American Journal of Epidemiology in May. Now, the FDA posted a warning on July 1 on its
website about hydroxychloroquine used in outpatients, but we can discuss this later; the FDA 
has had no systematic evidence in outpatients and erroneously extrapolated from hospital
inpatients to outpatients, what I said earlier was invalid.
About studies of hydroxychloroquine early use in high-risk outpatients, every one of them, and
there are now seven studies, has shown significant benefit: 636 outpatients in São Paulo, Brazil;
199 clinic patients in Marseille, France; 717 patients across a large HMO network in Brazil; 226
nursing-home patients in Marseille; 1,247 outpatients in New Jersey; 100 long-term care
institution patients in Andorra (between France and Spain); and 7,892 patients across Saudi
Arabia. All these studies pertain to the early treatment of high-risk outpatients—and all
showed about 50 percent or greater reductions in hospitalization or death. The Saudi study
was a national study and showed 5-fold reduction in mortality for hydroxychloroquine plus zinc
vs zinc alone. Not a single fatal cardiac arrhythmia was reported among these thousands of
patients attributable to the hydroxychloroquine. These are the non-randomized but controlled
trials that have been published.
Now we also know that all of the outpatient randomized controlled trials this year also together
show statistically significant benefit. These six studies comprised generally much younger
patients, only a fraction of whom were at high risk, so they individually had too few
hospitalizations or deaths to be statistically significant. But they all suggested lower risks with
hydroxychloroquine use, and when they were analyzed together in meta-analysis as my
colleagues and I found, this lower risk was statistically significant across the studies.
We have spent the last six months with formal government policies and warnings against early
outpatient treatment, with large government investments in vaccines and expensive new
treatments yet to be proven and almost no support of inexpensive but useful medications, and
a quarter of a million Americans have died from this mismanaged approach. Even with newly
promising vaccines, we have almost no information about how they will perform in older and
high-risk patients, in whom respiratory virus vaccines are known to have weak efficacy; it will
be a number of months before they become widely available; and we don’t know how long
vaccine immunity will last, or even if the vaccines will work for the newly increasing mutant
strains of the virus. As I have said on many occasions, the evidence for benefit of
hydroxychloroquine used early in high-risk outpatients is extremely strong, and the evidence
against harm is also equally strong. This body of evidence dramatically outweighs the
risk/benefit evidence for remdesivir, monoclonal antibodies or the difficult to use
bamlanivimab that the FDA has approved for emergency use authorizations while denying the
emergency use authorization for hydroxychloroquine. This egregious double standard for
hydroxychloroquine needs to be overturned immediately and its emergency use authorization
application approved. This is how we will get on the road to early outpatient treatment and the
major curtailment of mortality. Thank you.
References
Barbosa Esper R, Souza da Silva R, Teiichi Costa Oikawa F, et al. Empirical treatment with
hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by
telemedicine. April 15, 2020. Accessed April 30, 2020.
https://pgibertie.files.wordpress.com/2020/04/2020.04.15-journal-manuscript-final.pdf
Heras E, Garibaldi P, Boix M, et al. COVID-19 mortality risk factors in older people in a longterm care center. Preprints September 9, 2020. https://doi.org/10.21203/rs.3.rs-70219/v2
Ip A, Ahn J, Zhou Y, et al. Hydroxychloroquine in the treatment of outpatients with mildly
symptomatic COVID-19: A multi-center observational study. Preprints August 25, 2020.
https://doi.org/10.1101/2020.08.20.20178772
Ladapo JA, McKinnon JE, McCullough PA, Risch HA. Randomized Controlled Trials of Early
Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and
Death: Meta-Analysis. Preprints September 30, 2020.
https://doi.org/10.1101/2020.09.30.20204693
Lagier JC, Million M, Gautret P, et al. Outcomes of 3,737 COVID-19 patients treated with
hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective
analysis. Travel Med Infect Dis 2020 Jun 25:101791.
https://www.sciencedirect.com/science/article/pii/S1477893920302817
Ly TDA, Zanini D, Laforge V, Arlotto S, Gentile S, Mendizabal H, Finaud M, Morel D, Quenette O,
Malfuson-Clot-Faybesse P, Midejean A, Le-Dinh P, Daher G, Labarriere B, Morel-Roux AM,
Coquet A, Augier P, Parola P, Chabriere E, Raoult D, Gautret P. Pattern of SARS-CoV-2 infection
among dependant elderly residents living in long-term care facilities in Marseille, France,
March-June 2020. Int J Antimicrob Agents. 2020 Nov 6:106219.
https://www.sciencedirect.com/science/article/pii/S0924857920304301
Risch HA. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That
Should Be Ramped Up Immediately as Key to the Pandemic Crisis. Am J Epidemiol. 2020 Nov
2;189(11):1218-1226. https://academic.oup.com/aje/article/189/11/1218/5847586
Sulaiman T, Mohana A, Alawdah L, et al. The effect of early hydroxychloroquine-based therapy
in COVID-19 patients in ambulatory care settings: A nationwide prospective cohort study.
Preprints September 13, 2020. https://doi.org/10.1101/2020.09.09.20184143
Szente Fonseca SN, de Queiroz Sousa A, Wolkoff AG, Moreira MS, Pinto BC, Valente Takeda CF,
Rebouças E, Vasconcellos Abdon AP, Nascimento ALA, Risch HA. Risk of hospitalization for
Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis. Travel
Med Infect Dis. 2020 Oct 31;38:101906.
https://www.sciencedirect.com/science/article/pii/S1477893920304026

The Gary Null Show - 01.27.21

The loss of the individual and diversity in the wake of increasing cultural uniformity

Prof. Russell Jacoby is a professor of History at the University of California at Los Angeles and the holder of the Moishe Gonzales Chair of Critical Thinking at the University of California at Los Angeles where he teaches twentieth century European and American intellectual history.  He was featured in the documentary "Velvet Prisons: Russell Jacoby on American Academia"   He has published about ten books addressing the culture wars in education, multiculturalism, the politics of apathy, the history of violence, the decline of the intellectual class, and utopian idealism. His most recent book is "On Diversity: The Eclipse of the Individual in a Global Era" (Seven Stories Press), which warns us about the soulless uniformity that is being framed beneath the banner of diversity. Russell's work has earned him many notable fans including Howard Zinn and Gore Vidal. He holds degrees from the University of Chicago, the University of Wisconsin and earned his doctorate from the University of Rochester. 

The Gary Null Show - 01.26.21

The Rise of the Democratic Party and the backlash against free speech

Danny Sheehan is one of our nation’s most important and influential Constitutional and public interest lawyers.  During the past 45 years he has handled such public interest cases as the Pentagon Papers, the Watergate Break In, Iran Contra and the Silkwood murder case.  He has represented victims of he Three Mile Island nuclear disaster and fought against the American Nazi Party on hate crimes. He has been a lead attorney on behalf of the Native nations at Standing Rock and handling the dismissal of a federal case against Chase Iron Eyes for inciting a riot and felony trespassing. Danny is the founder of the Romero Institute, a nonprofit public policy center in Santa Cruz California. And more recently he founded the New Paradigm Institute which explores new pathways to world peace. He holds a law degree and divinity degrees from Harvard University.  Danny is the author of “The People’s Advocate: The Life and Legal History of America’s Most Fearless Public Defence Lawyer,”   And his websites are DanielPSheehan.com   AND   RomeroInstitute.org

The Gary Null Show - 01.25.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

The Covid-19 Pandemic as a Psychological Coup d’Etat

Richard Gale and Gary Null PhD

Progressive Radio Network, January 25, 2021

We have almost reached a full year since the spread of SARS-Cov2 was proclaimed a pandemic.  If we are to believe the World Health Organization’s and individual governments’ official statistics, the number of confirmed cases is reaching 100 million with over 2 million deaths. Indeed, if these numbers can be relied upon, we can surely acknowledge there is a real pandemic. It would be common sense, therefore, to expect, in fact demand, international health agencies and governments to make every effort to identify the virus’ origin.  Suspicions that the virus, now responsible for the spectrum of medical symptoms known as Covid-19, may have been bioengineered and escaped from a maximum security BSL-4 lab in Wuhan, China, were already voiced within a month after its identification was first reported.   Several highly respected medical experts, including Dr. David Relman at Stanford University, have suggested there is a strong likelihood that the virus escaped the Wuhan facility. To date, early queries about its origins remain unanswered and new questions are mounting. 

Recently, Jamie Metzl, a WHO advisor who earlier served under Biden in the Senate and in Bill Clinton’s National Security Council and State Department, told the Toronto Sun that the hypothesis of the virus’ natural origin in a Wuhan wet market is “a lie.”  It is no secret, Metzl noted, that the Wuhan Institute of Virology was heavily engaged in “gain of function” research to “amplify the virility of viruses.”

That there is very reasonable evidence that coronaviruses were being engineered in a laboratory goes back to 2003 and perhaps earlier.  That year, many Russian medical scientists, including Moscow’s head epidemiologist Dr. Nikolai Filatov, shared their opinions that the first SARS outbreak originated from a bioweapons lab.

In January 2020, less than a month since the first reported case in Wuhan, Dr. Igor Nikulin, a former member of the United Nation’s Commission on Biological and Chemical Weapons, stated in an interview that the US has been funding biolaboratories throughout the world, such as Kazakhstan, Afghanistan, Pakistan, Taiwan, Philippines, etc, and “wherever there are these American biolaboratories, or near them, there are outbreaks of new diseases, often unknown.” This was also confirmed by the founding president of EcoHealth Alliance, Dr. Peter Daszak, a fundamental player in the saga of “gain of function” research on coronavirus and other viral pathogens.  During an interview at a scientific conference in Singapore in early December 2019, Daszak, less than a month before the first Covid-19 case in Wuhan, stated,

“You can manipulate them in the lab pretty easily… Spike protein drives a lot of what happens with the coronavirus. Zoonotic risk. So you can get the sequence, you can build the protein — and we work with Ralph Baric at [the University of North Carolina] to do this — and insert the backbone of another virus and do some work in the lab.”

Baric, by the way, told New York Magazine, “Can you rule out a laboratory escape? The answer in this case is probably not.”  Baric has first hand knowledge of this probability. In 2016, one of the researchers in his University of North Carolina biosafety Level 3 lab was bitten by a mouse infected with a bioengineered SARS coronavirus strain.  Worse, according to records obtained by ProPublica, the scientist was permitted to resume her life without quarantine.   Baric’s lab also encountered other incidents that could have potentially released its engineered viruses upon the American public, however the university has refused to provide details.  Back in 2015, Baric had warned that a bat virus could jump species and infect humans. 

In a study published in October 2003 for the Proceedings of the National Academy of Sciences, Baric and his colleagues had “assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into their component clones.”  This infectious coronavirus clone was subsequently patented but only after the CDC overruled the US Patent Office’s denial of issuance. That same year, Bill Gates appointed Anthony Fauci to serve on his foundation’s Global Grand Challenges Scientific Advisory Board.  Shortly thereafter efforts commenced to develop a SARS-CoV vaccine, which included Moderna and Johnson and Johnson. To date, Moderna has been granted over 130 federal US patents to develop a vaccine against SARSCoV-2, including a military DARPA grant for mRNA vaccine technology in 2013.

EcoHealth Alliance, according to Alexis Baden-Mayer, lead attorney and director for the Organic Consumers Association, has conducted remarkable investigative research into the “gain of function” studies and the primary individuals behind the overseeing and funding this research. She has discovered that the majority of EcoHealth’s funding derives from the US Department of Defense, the National Institutes of Health and Anthony Fauci.  Baden-Mayer’s probing inquiries uncovered a cabal of controversial figures, including Daszak, Baric and his Chinese colleague Dr. Shi Zheng-li at the Wuhan lab, Bill Gate’s Foundation director Scott Dowell, former Human and Health Services’ director Dr. Robert Kadlec and Anthony Fauci.  Together this group – a part of what journalist Brian Berletic has called the Pandemic Industrial Complex- has been engaged in private contracts with military bioweapons projects and virus hunting in the wild for “gain of function” studies for a couple decades. 

Curiously, there is another character deeply connected with Daszak and the “gain of function” studies sponsored by EcoHealth: David R Franz.  Franz serves as EcoHealth’s policy health advisor. According to Baden-Mayer, who has investigated Franz’s history and background, he was formally a commander at Ft. Detrick’s bioweapons laboratory that was working on “gain of function” studies on pathogens for developing bioweapons. He was also involved in the anthrax investigations shortly after 911, and was a colleague of Dr. Bruce Ivin who was accused for the release of encapsulated anthrax aerosol mailed to Congressional legislators shortly after his mysterious death. 

Recently, Dr. David Martin – founder of the company M-CAM and a fellow at the University of Virginia’s School of Business Management – released his dossier on Anthony Fauci summarizing over two decades of investigations into the very disturbing research and patents filed for “synthetically altering the Coronaviridae (the coronavirus family) for the express purpose of general research, pathogenic enhancement, detection, manipulation and potential therapeutic interventions.” Before the first SARS outbreak in 2003, Baric filed a patent for producing “an infectious, replication defective, coronavirus.” In other words, the University the North Carolina, with federal grants, was amplifying a coronavirus to make it more infectious. 

Despite the questionable nature of this patent’s and others’ filing status by the CDC, and because patent law forbids patenting any life form, the government and its laboratories sealed under contract, cornered the coronavirus market. In the event of a coronavirus outbreak, only those corporations or institutions that acquired licensure from the NIH would be permitted to work with these bioengineered viruses for developing therapeutic drugs and vaccines.

Controversy has arisen over the confusion about the actual number of Covid-19 deaths and whether or not many if not most deaths are due to other causes.  Deaths in the presence of SARS2 are not the same as deaths due to the virus.  We heard this narrative repeated before and stated directly by the CDC back in 2003.  During the first SARS outbreak, the CDC in its Morbidity and Mortality Weekly Report dated April 4, 2003 stated that “anyone showing signs of fever or respiratory symptoms who travelled in or near areas affected by the virus would be labeled a SARS patient despite many of these individuals being diagnosed with other respiratory illnesses.” 

David Martin has released his “The Fauci/Covid-19 Dossier,” a 205 page document citing specific charges against the CDC, Dr. Anthony Fauci and his National Institute of Allergies and Infectious Disease, and individuals engaged in coronavirus “gain of function” research for funding and allegedly conspiring to commit acts of terror, lying to Congress, conspiring to engage in criminal commercial activity, illegal clinical trials and market manipulation and allocation. These are serious charges and the data Martin has collated is near conclusive and deeply disturbing. The Dossier has been filed with the US Attorney General, and is essential reading for everyone to understand the details about how the current pandemic may be an orchestrated strategy unraveling over the course of twenty years.  

During a recent video appearance, Dr. Martin condensed the background of alleged corruption, illegal patents and preparatory planning for the pandemic long before the outbreak. Speaking at the February 2016 Forum on Medical and Public Health Preparedness for Catastrophic Events, Daszak stated,

“… until an infectious disease crisis is very real, present, and at an emergency threshold, it is often largely ignored. To sustain the funding base beyond the crisis, we need to increase public understanding of the need for MCMs [Medical Counter Measures] such as a pan-influenza or pan-coronavirus vaccine. A key driver is the media, and the economics follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of process.” 

It is important to observe how Daszak lays out a strategy for a coronavirus or influenza pandemic to be framed as a commercial opportunity for the benefit of corporations and their investors, and the role the media will play in maximizing such profit.  In retrospect, Daszak’s scenario has played out accurately according to plan. Worse, the pandemic is now being manipulated by the World Economic Forum, the IMF, Bill Gates and the transnational class of corporate and banking elites, as well as the Biden administration and the Chinese, British, Canadian and German governments, as an opportunity to completely restructure the global economy. This will necessitate a thorough overall of the entire economic system thereby strengthening the global institutionalization of commercial oversight that will eventually nullify the independence of the modern nation state.

Martin’s Dossier continues to outline a series of purported illegal actions to deal with the pandemic that Fauci has undertaken as head of NIAID. These include 1) acting against the American Medical Association’s April 2020 recommendation that “face masks should not be worn by healthy individuals from acquiring respiratory infections because there is no evidence to suggest that face masks worn by healthy individuals are effective in preventing people from becoming ill.” 2) acting against existing published studies that show “to date, not a single study has confirmed that social distancing of any population prevented the transmission of, or the infection by SARS CoV-2.” And 3) in violation of FTC Act 15 U.S.C. 41, no product or service can be advertised to “prevent, treat or cure human disease unless you possess competent and reliable evidence… substantiating that the claims are true at the time they are made.”  This third point applies to NIAID’s promotion of face masks as well as Fauci’s aggressive push to make the drug Remdesivir, which Fauci is personally financially invested in, as a first line for treatment. 

If these charges of illegal activity against sound scientific evidence, are true, they warrant a thorough investigation in an international criminal court to determine their motivations.  The mishandling of the pandemic has caused enormous suffering and deaths for billions of people. Lives and livelihoods have been completely upended and our leaders are telling us things will never return to the old normal. In the meantime, the dominant forces of capitalism, aside from profiting over this catastrophe, are now framing the pandemic as an opportunity that will further reconfigure all of our social structures, including commerce, education, transportation and monitoring healthcare. It is a coup d’état against civilization’s collective psyche to foment a regime change in behavior that will eventually turn humanity into the slaves of technology as a means for social conditioning. Our only weapon against the likes of Fauci, Gates, and the transnational class of elites is educating ourselves of the damning investigations being conducted by individuals such as Dr. David Martin, Alexis Baden-Mayer, Reiner Fuellmich, Robert Kennedy Jr and others who are making every effort to shed light on the darkness in Washington and governments around the world determined to launch a Brave New World.  

The Gary Null Show - 01.22.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy. https://www.davidmartin.world/wp-content/uploads/2021/01/The_Fauci_COVID-19_Dossier.pdf

The Gary Null Show - 01.21.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy. Research suggests amino acid L-cysteine may help reverse early onset Alzheimer disease. Study: Light, magnetic field, and ultrasound could help fight COVID-19. Psychological well-being declined during second wave of the pandemic - especially for men. MIND and Mediterranean diets associated with later onset of Parkinson's disease. 

The Gary Null Show - 01.20.21

Reasons to Question the Covid-19 Vaccination Narrative Gary Null PhD Progressive Radio Network, January 21, 2021 At this moment, hundreds of millions of people worldwide eagerly await the chance to be vaccinated against the SARS-2 virus. They have been given the assurance, through an endless barrage of media reports and commentaries, that these vaccines are safe and will prevent serious infection.  We are told they are 95 percent effective, so how can we do much better than that? However, after examining the documentation that has been made available so far, there are very clear and legitimate challenges to this massive global propaganda campaign.  Moreover, now that aggressive efforts are underway by governments and national health ministries for rapid vaccine deployment, we are beginning to receive a steady flow of reports about serious life-threatening injuries and deaths among people already receiving the first of two shots. The state of California’s head epidemiologist has called for halting the distribution of a specific lot number of Moderna’s vaccine after a series of concerning allergic reactions started occurring in clusters at various inoculation sites. Deaths in Norway after vaccination have risen to 33.  Norway is now warning against vaccinating older patients with pre-existing illnesses.  Last week a probe by the Paul Ehrlich Institute was launched after 10 elderly Germans died within 4 days of vaccination. Germany is also reporting many other severe side effects including anaphylaxis. In Israel, conditions of facial paralysis associated with Pfizer’s mRNA vaccine are worrying health authorities. One 23-year Israeli man was rushed to a hospital with a rare multisystem inflammatory syndrome within 24 hours of receiving the vaccine. Seemingly the man was already asymptomatic with the virus; this raises the question of whether the vaccine is more dangerous in people already infected – a medical concern that none of the SARS-Cov2 trials investigated nor were they ever designed to.  Israelis are becoming increasingly wary and suspicious of these new vaccines. Opinions in the Israel National News are stating that Pfizer has been using the nation as a staging ground for rolling out its Covid-19 vaccine, the first country to have done so. Netanyahu in effect signed up seven million citizens to unwittingly be participants in a grand experiment. Consequently, the Israeli people were deprived of sufficient information about Pfizer’s vaccine to make a personal risk-benefit analysis.  “What they [Israeli citizens] are being asked to inject is not a vaccine defined by the CDC as a product that stimulates a person’s immune system to produce immunity to a specific disease,” writes Jerusalem Health Wellness counselor Ilana Rachel Daniel in her oped, “rather it is an experimental and novel technology…. It is in fact a medical device, a physical device that comes in a molecular sized package.”  Pfizer, Moderna and Anthony Fauci have already made it abundantly clear that these vaccines are not intended to stop transmission but only to prevent serious illness. In the US, as of January 19th, 6,741 Americans having had serious enough vaccine adverse effects, with a total number of 29,081 events, that required special medical assistance or hospitalization after receiving the Moderna and Pfizer vaccines.  However this is only what has been recorded in the CDC’s Vaccine Adverse Events Reporting System (VAERS), which the public can access; it does not include adverse events reported in the separate Data Link reporting system, which is private and regarded as more thorough. These incidents and the new data being released about the vaccines compel us to return to an earlier question. How accurate were Moderna’s and Pfizer’s headlines last autumn proclaiming 95 percent effectiveness amidst great fanfare? The question has been readdressed even by the prestigious British Medical Journal.  Two weeks ago, the vaccine makers released more of their summary data.  The journal’s associate editor Peter Doshi has recently challenged the trustworthiness of the companies’ results.  The 95 percent efficacy was based solely on confirmed PCR tests, which itself is dubious because PCR was never developed to confirm nor diagnostically identify a live active viral infection.  What was not reported in the original press releases were the “suspected” and “unconfirmed” Covid-19 cases in both the vaccinated and placebo groups. After these cases are included in the calculation, the Pfizer vaccine’s effectiveness nosedives to approximately 19 percent, far below the 50 percent threshold to authorize its use, according to Doshi.  Evidently, Pfizer seemingly ignored the 3,410 unconfirmed Covid-19 cases from its original press release. Is this perhaps to increase stock price?  Or perhaps to raise Fauci’s and the nation’s adrenaline levels for a miracle on the horizon?  You decide. Another red flag in Pfizer’s initial report was the exclusion of 371 trial participants from their efficacy analysis.  Pfizer fails to explain the rationale for excluding these individuals. In the meantime, distribution of Moderna’s and Pfizer’s vaccines have entered warp speed. Not all of the data to support their efficacy and safety has been publicly released. Pfizer states it will do so upon request. Moderna will provide its raw data only after all of its cinical trials have been completed. But, nevertheless, we are persuaded to roll up our sleeves without hesitation. The British Medical Journal’s article warrants first page headlines on newspapers across the country. It raises a very serious issue that should scientifically thwart false hopes and dreams that these Covid-19 vaccines will save us. They may be far more effective as cash cows instead of effective prophylaxes. However, no major press has bothered to give it a nod. What should this tell us? How necessary are these vaccines in this war against SARS-Cov2?  Since we now have reliable evidence based upon the vaccine makers’ own data that they are likely far less effective than we have been led to believe, they will not prevent asymptomatic infection nor transmission. They carry certain risks. So should we believe that they will make life any better?  There is mounting data that the vaccine will not prevent infection. Over 12,000 Israelis have tested positive within two weeks after receiving the first vaccine dose, and cases are increasing for those who received a second dose as well. In addition, there is still no certainty for how long immunity will last, and we are being told that vaccinated persons will still need to wear masks and social distance. Ergo, what good are these vaccines? What we do know is that living a healthy lifestyle will strengthen our immune systems and help ward off serious infections of any kind. Second, there are safe, effective and very inexpensive drug regimens that can be followed during the early onset of symptoms.  Both hydroxychloroquine (HCQ) and Ivermectin have been safely used for half century. Hundreds of studies document their efficacy.  Thousands of physicians worldwide are coming forward to share their personal clinical experiences in their use to save lives and prevent unnecessary hospitalization.  What is remarkable is that Anthony Fauci, the federal health agencies and the media know this is true. This is not subjective or speculative hearsay. It is well documented in the National Library of Medicine and accessible to everyone after several mouse clicks on the Library’s website. It is not conspiracy, therefore, to suggest something foul has been unfolding. Not only were HCQ and Ivermectin unsoundly ridiculed as a first line of defense to treat Covid-19 infections, there was absolutely nothing offered in their stead.  In the case of HCQ, many states, such as New York, have made the drug unavailable even if doctors wish to prescribe it.  What can be the motive for this bizarre, surreal scenario that contradicts the very moral basis upon which the practice of medicine is founded?  It has also been shown that the dominant medical establishment efforts to prevent HCQ’s use included the publication of studies in major medical journals such as The Lancet and the New England Journal of Medicine attempting to conclude the drug was dangerous and posed serious risks. Yet these papers were later proven to be based on ill-founded data and research gathered by a shady private enterprise with no previous medical credibility. The studies were subsequently retracted. But the official recommendations against HCQ’s use were never lifted.  And not a single member of the mainstream media has broke ranks with any of Fauci’s latest statements. The fact that the US has failed to recommend and institute effective preventative protocols, other than masks, social distancing and lockdowns, is a definitive sign of gross, and perhaps intentional, negligence and very likely incompetence.  If a person tests positive, despite being asymptomatic, she or he is treated no different than those who exhibit signs of illness.  Yet humans have carried and spread infectious microbes throughout history without indications of illness.  Fortunately, a growing number of physicians, scientists and healthcare professionals are stating publicly their opposition to Washington’s draconian pandemic policies.  And these are otherwise conservative, mainstream doctors, by no means conspiracy theorists, who are also voicing concerns over the new generation of vaccines that are frankly unwarranted and will likely barely make a dent in changing anything.  Or, we may ask whether halting the pandemic is these vaccines’ real intention? Given governments’ horrendous track record of corruption and deceit, nothing should be left off the table as a possibility.  This is a lesson for everyone without hesitation to become wise, alert and discern everything that is being stated about the virus, the pandemic and our federal and corporate responses to curtail it.

The Gary Null Show - 01.19.21

The rapid decay of journalism and the rise of media censorship

Sharyl Attkisson is a five time Emmy Award winning journalist, author and now host of the TV program Full Measure with Sharyl Attkisson, which airs on various ABC, CBS, Fox and NBC stations around the nation. Earlier she worked with CNN, PBS, and eventually CBS for 21 years, where she also did a stint as an anchor for the CBS Evening News. Sharyl is also the recipient of the prestigious Edward Murrow award from the Radio Television News Association.  She is one of the few honest journalists who has won respect from the left, right and independents. She is the author of three New York Times best selling books dealing with her personal career and challenges in broadcasting and corporate and political operatives in the media. Her most recent publication is "Slanted: How the News Media Taught Us to Love Censorship and Hate Journalism."  Her website is SharylAttkisson.com and her TV program Full Measure can be heard Sundays at 9:30 am Eastern time. 

The Gary Null Show - 01.18.21

What is not be discussed and investigated in covid pandemic  

Dr. David Martin is a businessman,  public speaker, researcher and professor. He is the founding chairman of M-CAM Inc, an innovative leader in banking intangible asset finance that operates in over 160 countries and ethical economic development. He has been a consultant on innovative finance and humanitarian investment for nations throughout the world.  David is also the managing partner of Purple Funds and is a fellow and professor at the Darden Graduate School of Business Administration at the University of Virginia. In the past he has served as the the chair for economic innovation at the UN-Affiliated Intergovernmental Renewable Energy Organization and has been advisor for numerous central banks, the World Bank and the International Finance Corporation. Those who have watched the film Plandemic 2 will recognize Dr. Martin, who along with Bobby Kennedy provided the film with its real substance.  More about David and his companies and activities can be found at DavidMartin.World and M-CAM.com. He has also authored several books including "Coup d'Twelve: The Enterprise that Bought the Presidency" and "Lizards Eat Butterflies: An Antidote to the Self-Help Addiction."

The Gary Null Show - 01.15.21

The larger consequences of the assault on the Capitol and a new era of social and economic restructuring

Chris Hedges is one of our nation’s most insightful cultural critics, social and political activists and investigative journalists. He is also Presbyterian minister and a visiting university lecturer. For two decades Chris was a foreign correspondent in war zones and conflicts in Central America, the Middle East, Africa and the Balkans, having reported for The New York Times and other news outlets from over 50 countries.  While at the Times, he received the 2002 Pulitzer Prize for reporting on global terrorism. That same year he received Amnesty International’s Global Award for Human Rights Journalism.   Chris has authored many bestselling books. His most recent  is “America: The Farewell Tour”, a deep on-the-ground  account of America's accelerating economic, social and political decay and the nation's descent into fascism. Chris hosts the weekly TV program “On Contact,” with interviews prominent dissidents ignored by the media. It  airs every Saturday on Russian TV at RT.com  

The Gary Null Show - 01.14.21

The Gary Null Show is here to inform you on the best news in health, healing, the environment and all things political around the world. Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

The Gary Null Show - 01.13.21

The Gary Null Show - 01.12.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

Study shows that mindfulness can help ease the pain of breast cancer survivors University of Ottawa (Canada), January 6, 2021 A study led by University of Ottawa researchers provides empirical evidence that mindfulness has a significant impact on the brain of women suffering from neuropathic pain related to breast cancer treatment. The researchers showed that mindfulness-based stress reduction (MBSR) helps modulate neuropathic pain. Their findings could make a difference in the lives of many women. In Canada, over a quarter of a million women are expected to be diagnosed with breast cancer - the most diagnosed cancer among women worldwide - in 2020. In addition to the psychological impacts of breast cancer, approximately 20 to 50 percent of survivors report experiencing chronic neuropathic pain following treatment. We talked to senior author Dr. Andra Smith, Full Professor at the uOttawa School of Psychology, to learn more about the most recent findings published in the journal Mindfulness. Why did you and your team decide to look at mindfulness to improve pain-related problems? "Neuropathic pain is a very common side effect of chemotherapy and other breast cancer treatments. Pain killers do not always work and quality of life, cognitive abilities, and overall well-being can be reduced due to this pain. Due to these negative effects and the complexity of treatment for this type of pain following breast cancer treatment, it is important to provide adjunct treatment and management options. We have heard a lot about mindfulness over the past few years, about how it helps people relax and feel better. If mindfulness, a non-pharmacological tool, can be used to help with neuropathic pain, women will feel better and might not experience such disruptive pain. Pain is a subjective experience and mindfulness is often dismissed as a "buzz word." But our research provides objective, empirical evidence of a significant impact of mindfulness on the brain of these women." How was the research conducted? "We investigated the impact of an 8-week mindfulness-based stress reduction (MBSR) program on emotional reactivity among a sample of breast cancer survivors with chronic neuropathic pain. We used state-of-the-art brain imaging at The Ottawa Hospital, on their 3T MRI scanner and collected data on white matter health, brain activity during emotional pain related word processing and during resting state. Women with neuropathic pain were imaged before and after an MBSR program, or treatment as usual. Pain, quality of life, and imaging were compared between the two groups and within the MBSR group pre- and post-MBSR." What did you find? "We observed major reductions in brain activity following mindfulness-based stress reduction in regions related to pain, emotional regulation, and cognitive processing. Both pain severity and pain interference, for the MBSR group, were significantly reduced after the 8-week training. Our results show a significant improvement in brain health as well as in pain perception. There are many anecdotal reports of how this or that made a person "feel better" but the really exciting results here are that we can see that there are actual changes in the brain and the way a person can alter their response to pain." Why is it important? "This research provides hope for a non-invasive method of easing the struggle of chronic neuropathic pain in women following breast cancer treatment. Pain is something that people fear, and many people run into significant secondary problems because of their pain medication use, including drug misuse and mental health issues. Mindfulness has a neurophysiological effect that can alter one's perception of pain. This research shows that there are adjunctive treatment options. If used properly, the information we have published can improve health outcomes for the people involved and could potentially also reduce health costs, as well as some of the related problems - particularly those related to mental health." Who worked on this research? "Dr. Patricia Poulin, at The Ottawa Hospital, was the clinical principal investigator with her research team of Heather Romanow, Yaad Shergill, Emily Tennant, and Eve-Ling Khoo. This included recruitment of the women and all clinical assessments. My lab performed the scanning component of the study, including my imaging team of Dr. Taylor Hatchard, Ola Mioduszewski and Dr. Lydia Fang. The data was collected over two years, from 2017 to 2019, funded by both Canadian Institutes of Health Research (CIHR) and Canadian Breast Cancer Foundation grants. We published three articles on our research in the last four months. The latest, "Reduced Emotional Reactivity in Breast Cancer Survivors with Chronic Neuropathic Pain Following Mindfulness-Based Stress Reduction (MBSR): an fMRI Pilot Investigation" was published in November 2020 in the journal Mindfulness." Moderate calcium intake, supplementation associated with reduced mortality risk during up to two decades of follow-up University of Aberdeen (UK), January 6 2021. A study and meta-analysis reported on December 31, 2020 in the European Journal of Epidemiology found a lower risk of premature mortality from any cause among men and women who consumed moderate amounts of calcium. Supplementing with calcium was associated with a lower risk of mortality from all causes among women. Tiberiu A. Pana and colleagues conducted a study that examined the effects of calcium among 17,968 participants in the European Prospective Investigation of Cancer, Norfolk (EPIC-Norfolk). The results were then included in a meta-analysis of 26 studies with a total of 1,828,149 subjects that evaluated the association between calcium intake and all-cause mortality, cardiovascular mortality, and incident cardiovascular disease, aortic stenosis, heart failure, myocardial infarction, peripheral vascular disease and stroke. When divided into fifths according to amount of their calcium intake, EPIC-Norfolk participants whose intake of calcium was between 771 mg and 926 mg per day had a 9% lower risk of dying from any cause and participants whose intake was 1074 mg to 1254 mg had a 15% lower risk in comparison with subjects whose intake was among the lowest fifth at less than 770 mg. Cardiovascular disease mortality was also reduced in these groups. A moderate intake of calcium was associated with a significantly lower risk of stroke, while the reduction in risk associated with an intake of more than 1255 mg per day failed to reach significance. The meta-analysis found a lower risk of all-cause mortality in association with higher calcium intake compared to lower intake. Calcium supplementation was associated with lower all-cause mortality among women, while no significant association was observed among men. “Moderate dietary calcium intake may protect against cardiovascular and all-cause mortality and incident stroke,” the authors concluded. Health benefits of replacing wheat flour with chickpea flour Kings College London and Quadram Institute, January 11, 2021 Researchers from the Quadram Institute and King's College London have shown that replacing wheat flour with a new ingredient derived from chickpeas improved the glycaemic response of people eating white bread. The ingredient uses specially developed milling and drying processes that preserves cellular structure, making its starch more resistant to digestion. Developing food products that contain more of this resistant starch would help to control blood glucose levels and reduce risk of type 2 diabetes. Starch from wheat is a major source of dietary carbohydrate, but in bread and many other processed foods it is quickly digested to glucose in the body, causing a large spike in blood glucose levels. There is a large body of evidence that links long-term consumption of foods that provoke high glycaemic responses to the development of Type II diabetes. With this condition on the rise, along with obesity and other metabolic disorders, providing foods and ingredients that help consumers better manage blood glucose could help combat these challenges to health. Many pulses, such as chickpeas, peas, beans and lentils naturally contain high amounts of resistant starch, which is digested slowly and avoids potentially damaging blood glucose spikes. But most of this beneficial resistance is lost, rendering the starch highly digestible, when these crops are milled to flour and processed into a food product. For this reason, the scientists invented an alternative milling process, which preserves the plant cell wall structures (dietary fiber) that surround the starch. This 'Type 1' resistant starch is the same as that found in wholefoods, but this new ingredient can be used in a form that potentially allows it to be incorporated into a wider range of foods. Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UKRI, was used to develop the commercial potential of this novel ingredient, referred to as PulseON, and expands the possibilities for including large amounts of resistant starch in processed foods to improve nutritional quality. And now, in a new study published in the journal Food Hydrocolloids, the research team shows for the first time that the resistant property of the starch is retained during bread making, and that people who ate bread rolls where some wheat flourwas replaced by PulseON had lower blood glucose responses. In a double blind randomized cross over study, the scientists replaced 0%, 30% or 60% of the wheat flour in a standard white wheat bread recipe with PulseON. Healthy human participants consumed each type of bread roll type for breakfast in random order on separate days, with no knowledge of which type of roll they were eating. Their glucose levels were recorded using continuous glucose monitors. Blood glucose responses to the PulseON enriched breads were on average 40% lower than after eating the control breads. All bread rolls contained similar amounts of starch and wheat protein (gluten) per serving, so the different blood glucose responses reflect the carbohydrate quality. These results raise the possibility of using such foods for improving the dietary management of diabetes, which needs to be evaluated in future studies. The digestion of starch in each bread type was also studied in a laboratory using biochemical and microscopy techniques. These experiments showed that after two hours of digestion, the wheat starch had been digested, but the type-1-resistant starch remained. This confirms that the lower glucose response to PulseON enriched breads was due to the resistant starch enclosed in the chickpea ingredient not being digested. "Incorporating our new type of flour into bread and other staple foods provides an opportunity to develop the next generation of low glycaemic food products to support public health measures to improve health through better diets" said Dr. Cathrina Edwards from the Quadram Institute. "Consumers replacing wheat bread with PulseON enriched bread would benefit not only from the type 1 resistant starch, but also from the higher fiber and protein content." For widespread acceptance, the qualities of the products such as their taste, texture and appearance need to match those that are so popular with consumers. Participants gave the PulseON enriched breads similar scores for texture and taste as the white bread. Quality tests indicated that any effects on bread quality (texture, appearance) were subtle and most noticeable when large amounts of PulseON were used. The sensory properties need to be confirmed with a broader consumer group in a non-clinical setting, but are very encouraging for efforts to produce healthier white bread without adverse effect on product quality. The technology is patent-protected and the group are looking at commercial exploitation. Previous research from the same group has shown that the same milling process may be applied to other beans, lentils and pulses, resulting in cellular powders high in resistant starch, but with different colors and flavors. The researchers are now exploring ingredient applications in a broader range of foodproducts, and planning further trials involving those with prediabetes and type 2 diabetes. Traditional Chinese water-only fasting associated with reduced thrombosis risk Soochow University School of Medicine (China), January 4, 2021 According to news reporting based on a preprint abstract, our journalists obtained the following quote sourced from medrxiv.org: “Beego is a traditional Chinese complete water-only fasting practice initially developed for spiritual purposes, later extending to physical fitness purposes. Beego notably includes a psychological induction component that includes meditation and abdominal breathing, light body exercise, and ends with a specific gradual refeeding program before returning to a normal diet. Beego has regained its popularity in recent decades in China as a strategy for helping people in subhealthy conditions or with metabolic syndrome, but we are unaware of any studies examining the biological effects of this practice. “To address this, we here performed a longitudinal study of beego comprising fasting (7 and 14 day cohorts) and a 7-day programmed refeeding phase. “In addition to detecting improvements in cardiovascular physiology and selective reduction of blood pressure in hypertensive subjects, we observed that beego decreased blood triacylglycerol (TG) selectively in TG-high subjects and increased cholesterol in all subjects during fasting; however, the cholesterol levels were normalized after completion of the refeeding program. Strikingly, beego reduced platelet formation, activation, aggregation, and degranulation, resulting in an alleviated thrombosis risk, yet maintained hemostasis by sustaining levels of coagulation factors and other hemostatic proteins. Mechanistically, we speculate that downregulation of G6B and MYL9 may influence the observed beego-mediated reduction in platelets. Fundamentally, our study supports that supervised beego reduces thrombosis risk without compromising hemostasis capacity. Moreover, our results support that beego under medical supervision can be implemented as noninvasive intervention for reducing thrombosis risk, and suggest several lines of intriguing inquiry for future studies about this fasting practice Assessing the antimicrobial activity of flaxseed NGH Institute of Dental Sciences & Research Centre (India), January 5, 2021 Researchers in India evaluated the antimicrobial activity of flaxseed against known periodontal pathogens. They reported their findings in an article published in the International Journal of Herbal Medicine. Research suggests that the use of antibiotics is beneficial in the management of periodontitis. However, antibiotic resistance has now become a major global issue, and it is believed to have stemmed from the misuse of antibiotics. Many researchers now see herbal interventions as therapeutic strategies that deserve more research and attention. Flaxseed, a popular superfood rich in omega-3 fatty acids, has demonstrated potent antimicrobial and anti-biofilm activities in several studies. To further explore its potential, the researchers conducted an in vitro study that aims to assess the antimicrobial activity of flaxseed against periodontal pathogens. They prepared an ethanolic extract from flaxseed powder and determined its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitansand Tannerella forsythia. The researchers reported that the flaxseed extract exhibited bacteriostatic activities against all three pathogens. At 100 microliters (uL)/milliliter (mL), the extract exerted bactericidal effects against P. gingivalis. Based on these findings, the researchers concluded that flaxseed can be used as a natural adjunct to periodontal therapy because of its bactericidal effects against P. gingivalis. Vitamin B3 may benefit those with Parkinson's disease University of Leicester, January 11, 2021 Individuals with a specific type of Parkinson's disease (PD) could gain from increasing vitamin B3 (niacin) content in their diet, say British investigators. The findings point to niacin’s ability to increase levels of a compound responsible for energy generation and DNA repair. These factors — if left unattended — result in faulty mitochondria function that contributes to the progression of the neuro-degenerative disorder. "This study strengthens the therapeutic potential for Vitamin B3/niacin-based dietary interventions in the treatment of Parkinson's disease," said Dr Miguel Martins, lead study author and programme leader of the MRC Toxicology Unit at the University of Leicester. Niacin or Vitamin B3 is found in a number of foods, including liver, chicken, beef, fish, cereal, peanuts, and legumes. It can also be made from tryptophan, an essential amino acid found in most forms of protein. The team began by looking at studying fruit flies, specifically bred with a mutation that mimics PD. These flies specifically had a mutated form of the PINK1 gene that normally protects cells from stress-induced mitochondrial malfunction.   Flies were then fed food supplemented with niacin, which is made into the compound NAD inside the body. With this additional source of NAD, the researchers found flies had a lower number of faulty mitochondria than their mutant cohorts fed a regular diet. In addition, niacin also prevented the flies from losing existing neurons. “Mutations in PINK1 prevent cells from clearing out the defective powerhouses. When they accumulate, neurons can't get enough energy and die. The faulty mitochondria also release toxic molecules that damage their genes encoded by DNA,” said Dr Martins. “With all the mitochondrial damage going on, we wondered if in cases of Parkinson's the NAD compound ends up in short supply." The team also found that stopping DNA repair from depleting NAD kept mitochondria healthy and neurons alive, as well as enhance the flies' strength, mobility and lifespan. "The results suggest that in familial Parkinson's, available NAD is critical for keeping mitochondria in shape and the disease at bay,” said Dr Martins. While drug treatments exist that block NAD-consumption during the DNA repair process, Dr Martins thought increasing dietary niacin could provide certain benefits. "While neither of these would be cures, they would expand treatment options for Parkinson's patients with faulty mitochondria,” he added. excluded Study finds unfavorable intestinal microflora levels associated with the development of postmenopausal osteoporosis Fujin University (China), December 27, 2020 According to news reporting originating from Fujian, People’s Republic of China, research stated, “We aimed to investigate the intestinal microecology and fibroblast growth factor (FGF) expression in women with postmenopausal osteoporosis (PMO) and their clinical value in the diagnosis of PMO. A total of 214 postmenopausal women were analyzed retrospectively.” Our news editors obtained a quote from the research from the Department of Orthopedics, “The women were divided into the abnormal group (103 cases) and the normal group (111 cases) according to their bone mineral density (BMD). The levels of intestinal microflora and serum FGF-21, FGF-23, alpha-klotho, and beta-klotho were compared between the two groups, and the correlations of intestinal microflora, FGF-23, alpha-klotho, and beta-klotho with BMD were analyzed. The women in the abnormal group were further divided into the osteoporosis subgroup (59 cases) and the osteopenia subgroup (44 cases) for comparison. Receiver operating characteristic (ROC) curve was plotted to analyze the diagnostic value of intestinal microflora, FGF-23, alpha-klotho and beta-klotho for PMO. Compared with the normal group, the abnormal group had lower levels of bifidobacterium, lactobacillus, alpha-klotho, and beta-klotho and higher levels of enterococcus and FGF-23 (all P<0.05). BMD was closely correlated with the levels of intestinal microflora, FGF23, alpha-klotho, and beta-klotho (all P<0.05). Compared with the osteopenia group, the osteoporosis group had lower levels of bifidobacterium, lactobacillus, alpha-klotho, and beta-klotho and higher levels of enterococcus and FGF-23 (all P<0.05). ROC analysis revealed the clinical value of lactobacillus, bifidobacterium, enterococcus, FGF-23, alpha-klotho, and beta-klotho in diagnosing PMO (all area under the curve >0.70).” According to the news editors, the research concluded: “The levels of intestinal microflora and serum FGF-23, alpha-klotho, and beta-klotho are closely associated with the development of PMO, and these markers have clinical value in the diagnosis of PMO.” This research has been peer-reviewed.

The Gary Null Show - 01.11.21

Gary takes on the real issues that the mainstream media is afraid to tackle. Tune in to find out the latest about health news, healing, politics, and the economy.

The Gary Null Show - 01.08.21

The case against the FCC health guidelines for 5G and wireless technology

Dafna Tachover is an attorney and the Director of the 5G Wireless Harms project at Robert Kennedy's Children's Health Defense. She is the founder of the advocacy organization We Are The Evidence which is dedicated to protecting the rights of children and adults who have been injured by wireless electromagnetic radiation. Earlier Dafna served as a telecommunications and computers officer in the Israeli Defense Forces where she was the commander of the computer center of its military headquarters and operation center. In 2012 she led a Supreme Court case in Israel to replace the use of Wi-fi in schools with wired networks, the first successful effort to limit wi-fi use in schools worldwide.  Currently she is spearheading the Children's Health Defense's landmark case against the FCC's health guidelines on wireless radiation. The Children's Health Defense website is ChildrensHealthDefense.org, where you can find a section of important articles and information about 5G and the health risks of wireless technology. 

The Gary Null Show - 01.07.21

The Gary Null Show is here to inform you on the best news in health, healing, the environment and all things political around the world.

Will the Covid Vaccine Meet Its Quixotic Promises?

Gary Null and Richard Gale

Progressive Radio Network, January 7, 2021

Daily we hear and observe a stream of endless propaganda about the miracles of the new generation of Covid vaccines in order to calm fears and increase public compliance. Top health officials, popular politicians and celebrities are jumping before the cameras to be the first to receive injections. In unison, editors at the New York Times, Washington Post and the major multimedia networks encourage everyone to be vaccinated as soon as enough vaccines are available. Anthony Fauci and the captains in the pandemic efforts claim Moderna’s and Pfizer’s vaccines are about 95 percent effective, and the Department of Health and Human Services is convincing us they are safe and effective.  Therefore, we should all willing stand in the waiting line. There is nothing to be concerned about, we are told, except those anti-vaccine heretics, who the World Health Organization has now dubbed among the ten most dangerous risks to global health.  

The Gary Null Show - 01.06.20

The Gary Null Show is here to inform you on the best news in health, healing, the environment and all things political around the world. Hello Fellow Freedom Fighters, It appears the NYS assembly will vote on Bill A-416 this Wed, 1/6, which would allow the Governor and health authorities to detain and forcibly vaccinate New Yorkers without normal due process.  WE MUST OPPOSE THIS BILL.  Link to Bill A-416: https://www.nysenate.gov/legislation/bills/2021/a416

The Gary Null Show - 01.05.21

Will the Covid Vaccine Meet Its Quixotic Promises?

Gary Null and Richard Gale

Progressive Radio Network, January 7, 2021

Daily we hear and observe a stream of endless propaganda about the miracles of the new generation of Covid vaccines in order to calm fears and increase public compliance. Top health officials, popular politicians and celebrities are jumping before the cameras to be the first to receive injections. In unison, editors at the New York Times, Washington Post and the major multimedia networks encourage everyone to be vaccinated as soon as enough vaccines are available. Anthony Fauci and the captains in the pandemic efforts claim Moderna’s and Pfizer’s vaccines are about 95 percent effective, and the Department of Health and Human Services is convincing us they are safe and effective.  Therefore, we should all willing stand in the waiting line. There is nothing to be concerned about, we are told, except those anti-vaccine heretics, who the World Health Organization has now dubbed among the ten most dangerous risks to global health.  

What the media blitzkrieg is ignoring are the very legitimate and even worrisome unanswered questions on the minds of many citizens. Aside from concerns over these vaccines’ uncertainties for effectiveness and safety due to quickly being fast tracked past the usual regulatory analyses and reviews, Moderna’s and Pfizer’s vaccines are largely experimental. Never before has an mRNA vaccine been distributed en masse to tens of millions of people. Other suspicions include 1) the length of time neutralizing antibodies are effective before immunity wanes, 2) what kind of protection the vaccines will actually offer, 3) does the data truly support Moderna and Pfizer claims that their vaccines are 95 percent effective, 4) are vaccine recipients protected from contracting the virus and if not can they transmit it to others, and 5) the absence of long-term safety profiles following vaccination that are still pending. The Pfizer Phase 3 trial lasted less than 4 months. Moderna only completed its COVE trial enrollment on October 22; now two months later people are receiving the vaccine. Therefore, insufficient time has lapsed to make any realistic clinical determination about either vaccine’s safety following months after vaccination.

Yet despite these questions, over half of Americans believe that being vaccinated will provide complete immunity from infection and therefore their lives will return to normal. Now the most recent narrative we are witnessing is stoking public fear that unless we are vaccinated we will be unable to board a plane or train, will be prevented from attending schools or public events, and may even become victims to more austere and harsh quarantine laws. There is also the lingering myth of the PCR test as a reliable standard for diagnosing Covid infections. Due to the widespread abuse of PCR, which was never designed nor intended to be relied upon as a confirmatory diagnostic tool, a growing number of medical experts argue that the US, the UK, Germany and other EU nations are facing a “casedemic” rather than a pandemic due to a pathogenic virus. Despite PCR’s high rate of misdiagnoses, positive results are still being reported as Covid cases. 

In early December, the New England Journal of Medicine published a National Institute of Allergy and Infectious Disease analysis of the Moderna vaccine’s length of efficacy based upon neutralizing antibody levels. This was the first data published of its kind for any of the Covid vaccines. Although the analysis only included 34 individuals who had received both shots, it found that antibody counts were significant over a 3 month period, averaging between 50-75 percent. The report stated this was “less than we were hoping for.”  The rate of antibody decline increased among the older trial participants.  This disappointing result should not be a surprise, although even a sharp drop in antibodies may still provide sufficient immunity, at least for some.  The most recent issue of the British Medical Journal reports that natural immunity following infection lasts approximately 6 months. Yet this study conducted by Oxford University Hospitals likely has serious flaws since it relied upon PCR for diagnosing the data.  Furthermore, Moderna has also been using its mRNA technology for vaccines against several influenza strains. A similar pattern of antibody decline was noted in their flu vaccines, showing effectiveness for about 6 months and then an antibody drop by as much 90 percent. 

So how much protection will the new mRNA Covid vaccines provide and for how long?  Only time and further monitoring of vaccine recipients will tell. 

Another important question on people’s minds is whether they can still be infected after vaccination and whether they can transmit the virus to others.  In principle, vaccine proponents argue that vaccines prevent both infection and transmission.  But the data does not support this conclusion. It is well known that persons vaccinated against the flu will frequently contract the virus, become ill and spread it to others.  This is largely because we are dealing with viruses that enter the upper respiratory tract by way of the mucous layer in the nose and throat.  Mucous itself slows down the spread of the virus to the lungs. However, it is also an obstacle for antibodies and immune cells, such as T-cells, from reaching the multiplying virus.  For this reason, Anthony Fauci has continued to state that vaccinated persons should continue to wear masks and observe social distancing to avoid transmitting the virus. The World Health Organization has stated that there is no “evidence on any of the vaccines to be confident that it’s going to prevent people from actually getting the infection and therefore being able to pass it on.”

Back in October, Dr. Peter Doshi, at the time an editor for the British Medical Journal, had already warned that the later vaccine clinical trials were never properly designed to determine whether it would reduce the likelihood of falling ill nor prevent infection. In a later article Doshi questions the vaccines’ purported 95 percent efficacy based upon how the results are being reported and the ambiguity between “suspected” and “confirmed” Covid cases among the trial participants who received the vaccine.  If the “suspected” cases are included, there is a 20-fold higher number of vaccinated individuals who later contracted the virus.  However, Doshi reminds us that neither Pfizer nor Moderna have provided the raw data for public scrutiny. Moderna says it will make the data available after the trial is completed, which will be in 2022.  Repeatedly Bill Gates, Fauci and all of the media pundits tell us that unless there is large vaccination compliance, the transmission of Covid will never be interrupted. However, based upon what we are learning these new Covid vaccines have always been and remain an unsupported illusion to realistically end the pandemic. 

Another important piece of information that is very rarely mentioned is Covid-19’s 4-5 day incubation period. In the event a person is asymptomatically infected with the virus, the CDC states,

“mRNA vaccines are not currently recommended for outbreak management or for post-exposure prophylaxis, which is vaccination to prevent the development of SARS-CoV-2 infection in a person with a specific known exposure. Because the median incubation period of SARS-CoV-2 is 4 to 5 days, it is unlikely that the first dose of COVID-19 vaccine would provide an adequate immune response within the incubation period for effective post-exposure prophylaxis. Thus, vaccination is unlikely to be effective in preventing disease following an exposure.”

Reports are already coming in to confirm this. Recently, hundreds of Israelis became infected with the virus after receiving Pfizer’s Covid vaccine. There may be several reasons for this.  First, were the vaccine recipients already carrying the virus at the time of vaccination? Second, it takes 8-10 days for immunity to sufficiently increase after receiving the vaccine, and after the first dose there is only about 50 percent efficacy.  This is why the second shot for the mRNA vaccines is so critical in order to reach the magical 95 percent effectiveness. 

Now that the Moderna and Pfizer vaccines are being administered throughout the US – 4.6 million recipients since January 4th – and in other nations, we are beginning to read reports about serious adverse effects. Recently Covid vaccine injuries have started to be reported in the CDC’s Vaccine Adverse Event Reporting System (VAERS). During a seven-day period, December 15-22, there were 1,158 cases entered. However, this is but a fraction, albeit significant, of the actual number of adverse events. On December 19, the CDC’s Advisory Committee on Immunization Practices convened to review the cases of life-threatening anaphylaxis following mRNA vaccination. In his presentation to the Working Group, Dr. Thomas Clark presented statistics showing that there was a minimum of 3,150 “health impact events” among 112,807 vaccine recipients (2.7 percent) during only a five-day period (December 14-18).  Moreover, these 3,150 adverse events were tagged as “unable to perform normal daily activities, unable to work, required care from a doctor or health care professional.”  The presentation did not include the number of minor and moderate adverse events which are likely much higher. 

In early October we reported on Covid-19 vaccine risks stated by Dr. Sucharit Bhakdi, the former chair of microbiology at the University of Mainz Medical School in Germany. Among those risks is the possibility of the vaccine’s mRNA contributing to mutogenesis in reproductive cells that may be inherited later by children. Subsequently, the University of Miami has reported it is following up on its earlier discovery of the virus present in men’s testicles up to six months after infection. Now the researchers are investigating whether the vaccine’s Covid genetic information may do likewise and interfere with sperm quality and reproduction. 

The final question is why are we failing to discuss, let alone adhere, to the precautionary principle before this massive undertaking to produce and distribute potentially billions of vaccines to inoculate the global population? The precautionary principle quite simply states that any new medical intervention with results that are either disputed or unknown should be avoided. In fact, the principle has frequently been invoked for products or processes that would introduce genetically modified organisms or foods for consumption. Now we are injecting questionable genetically engineered substances into human bodies, and worse there are voices that want to mandate this enormously expensive experiment long before any reliable medical consensus can be reached on their long-term safety. 

If the precautionary principle had been respected and honored during the past 100 years, the US would have prevented untold numbers of life-long injuries and deaths due to the public advertising of smoking, asbestos and DDT poisoning, synthetic hormone replacement, toxic pesticides such as Monsanto’s glyphosate, AZT during the early part of AIDS epidemic, and the swine flu and Gardasil vaccines that were also rushed to market without proper scientific oversight.  The US government has an atrocious track record for introducing toxic chemicals to the American public then denying all responsibility for their adverse effects and the indescribable suffering that their shortsightedness has caused. It is only well after the tragedy gains some public attention that a whistleblower or someone “in the know” comes forward to reveal the wrongdoings and corruption behind the companies developing these toxic products. And how often do we find the government, the regulatory agencies and mainstream media being the primary source to expose these felonies? Rarely ever. Even when protective laws are enacted, such as the Clean Air, Food, Water and Energy acts, corporate lobbyists and big money apply their trade to buy off legislators and heads of federal agencies to gradually scrub away these laws’ safeguards. This is part of the corporate cancel culture to erase our protections. 

These trends that have become ingrained into the government’s politick have led to today’s largest propaganda campaign in the country’s history and is now orchestrated by the CDC and NIH in collusion with the pharmaceutical industrial complex, Bill Gates, many of our leading corporate-funded medical schools and institutions and across the ideological spectrum of the media. All are heavily invested in the new generations of Covid vaccines and whatever new novel drugs in the pipeline and to invalidate the highly effective and cheap drugs, such as hydroxychloroquine and invermectin, that have been proven to treat Covid infections quickly and safety.  This is the same artifice of corporate scoundrels and their media escorts that have relied on faulty science, fabricate their own research to serve their financial interests, and hide behind a cloak of non-transparency who Fauci now encourages us to openheartedly trust as Covid vaccines reach your local clinics and downtown pharmacies.  

There may be no reason to doubt Fauci’s and our health agency’s sincerity and determination to protect the health of Americans during this crisis. However, their competency to do so effectively is an entirely different manner. Sadly their past track records of colluding and showing favoritism to private interests over public health should top the list of our worries.  Whatever the long term consequences from this massive vaccination campaign, praise, condemnation or even criminal accusations will ultimately rest upon the shoulders of our nation’s Anthony Fauci-s, Bill Gates and Moncef Slaoui-s.

The Gary Null Show - 01.04.21

The Gary Null Show is here to inform you on the best news in health, healing, the environment and all things political around the world. Studies uncover more positive effects associated with EPA, DHA. Neuroprotective effects of skullcap compounds against amyloid beta-induced toxicity. The microbiome and Alzheimer disease: potential of prebiotic, probiotic and synbiotic preparations. Melatonin inhibits glucose-induced programmed cell death in osteoblastic cells. A fat molecule unique to avocados can help lower diabetes risk by addressing insulin resistance. Witnessing fear in others can physically change brain, scientists say. Fish oil lowered oxidative stress markers and improved membrane fluidity in plasma of patients with probable Alzheimer disease. 

The Gary Null Show - New Years Day Special

The Gary Null Show is here to inform you on the best news in health, healing, the environment and all things political around the world.